AHA Comments to CMS on the International Pricing Index Model for Medicare Part B Drugs

AHA comments on the Centers for Medicare & Medicaid Services’ advance notice of proposed rulemaking on the International Pricing Index model for Medicare Part B drugs.

 

Sign In to Download the AHA Comments to CMS on the
International Pricing Index Model for Medicare Part B Drugs

Related Resources

Letter/Comment
AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions
Public
Infographics
Drug Prices and Shortages Increase Hospitals’ Costs and Jeopardize Patient Access to Care Infographic
AHA Center for Health Innovation Market Scan
3 Ways GLP-1 Drugs Could Impact Your Hospital’s Future
Guides/Reports
Costs of Caring
Public
Guides/Reports
2023 Costs of Caring
Public
Advisory
HRSA Finalizes 340B Administrative Dispute Resolution Process
Member